Nested Knowledge

Bringing Systematic Review to Life

User Tools

Site Tools


wiki:start:demo

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revision Previous revision
Next revision
Previous revision
wiki:start:demo [2022/02/11 04:25]
kholub
wiki:start:demo [2023/06/07 20:22] (current)
jthurnham [Non Small Cell Lung Cancer (NSCLC): Tyrosine kinase inhibitors (TKIs)]
Line 1: Line 1:
-Want to try out Nested Knowledge, but don't have a research question in mind? Don't want to make an upfront time investment building a nest? No problem, see how both AutoLit and Synthesis work from complete examples! The below links are walkthroughs of demos you may open from your [[https://nested-knowledge.com/gather|AutoLit Home]].+====== Demo Nests ======
  
-  * [[:wiki:start:demo:covid19|COVID-19: Antivirals]] +Want to try out Nested Knowledge, but don't have a research question in mind? Don't want to make an upfront time investment building a nest? No problem, see how both AutoLit and Synthesis work from complete examples!  
-  * [[:wiki:start:demo:osteoarthritis|OsteoarthritisTanezumab]] + 
-  * [[:wiki:start:demo:heart|Heart Failure: ACE Inhibitors & ARBs]]+{{youtube>NJmXN3FWYx4}} 
 + 
 + 
 +The below links are walkthroughs of demos you may open from your [[https://nested-knowledge.com/gather|AutoLit Home]] and clicking "Demo Nests" on the left hand side. 
 + 
 +{{:wiki:start:img190.png?nolink&  }} 
 + 
 +You have the choice of three different demo nests depending on your research project type! 
 + 
 +{{ :undefined:demonestss.png?nolink |}} 
 + 
 + 
 +==== COVID-19: Anti-virals ==== 
 + 
 +  Our [[:wiki:start:demo:covid19|COVID-19: Antivirals]] nest was [[https://pubmed.ncbi.nlm.nih.gov/35100985/|published]] in BMC Infectious Disease in January 2022. You can use a copy of the nest to practice searching the COVID-19 literature. 
 + 
 +==== Non Small Cell Lung Cancer (NSCLC): Tyrosine kinase inhibitors (TKIs) ==== 
 + 
 +  * Our [[:wiki:start:demo:hta_nsclc|NSCLCTyrosine Kinase Inhibitors]] nest examines the treatment of NSCLC with various types of tyrosine kinase inhibitors. This is based on a published [[https://icer.org/assessment/non-small-cell-lung-cancer-2016/ | Institute for Clinical and Economic Review (ICER) review]].  
 + 
 +//This nest is specifically designed to meet the requirements of Health Technology Assessment (HTA) body: [[https://www.nice.org.uk/about/what-we-do/our-programmes/nice-guidance/nice-guidelines#:~:text=NICE%20guidelines%20are%20evidence%2Dbased,in%20particular%20circumstances%20or%20settings.|National Institute for Health and Care Excellence (NICE).]]// 
 +==== Heart Failure: ACE Inhibitors & ARBs ==== 
 + 
 +  * Recent advances in ARBs, a new class of drug for heart failure with reduced ejection fraction, inspoired our [[:wiki:start:demo:heart|Heart Failure: ACE Inhibitors & ARBs]] nest. Here, we compare the more conventional drug class (ACE Inhibitors) against ARBs.
  
  
wiki/start/demo.1644553503.txt.gz · Last modified: 2022/02/11 04:25 by kholub